Current Status of the Diagnosis and Management of Osteoporosis
Open accessThe DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Abstract
Osteoporosis has been defined as the silent disease of the 21st century, becoming a public health risk due to its severity, chronicity and progression and affecting mainly postmenopausal women and older adults. Osteoporosis is characterized by an imbalance between bone resorption and bone production. It is diagnosed through different methods such as bone densitometry and dual X-rays. The treatment of this pathology focuses on different aspects. On the one hand, pharmacological treatments are characterized by the use of anti-resorptive drugs, as well as emerging regenerative medicine treatments such as cell therapies and the use of bioactive hydrogels. On the other hand, non-pharmacological treatments are associated with lifestyle habits that should be incorporated, such as physical activity, diet and the cessation of harmful habits such as a high consumption of alcohol or smoking. This review seeks to provide an overview of the theoretical basis in relation to bone biology, the existing methods for diagnosis and the treatments of osteoporosis, including the development of new strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Thus, it is thought that imbalances in these molecular and cellular processes alter bone homeostasis, driving the pathophysiology of osteoporosis [5,6].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“In addition to bone densitometry, general blood and urine tests can provide important information about an individual’s overall health and any underlying conditions that may be contributing to osteoporosis.”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“This classification is widely accepted as a diagnostic criterion, with sensitivity and specificity close to 90% [6].”
From Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics (2023) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–229 of 229
Kamimura, M., Nakamura, Y., Sugino, N., Uchiyama, S., Komatsu, M., Ikegami, S., Kato, H., & Taguchi, A. (2016) · Scientific Reports · doi:10.1038/srep29199 · Cited by 27 · cited 1×
“(iii) A loss of height, as vertebral fractures and hyperkyphosis can result in a decrease in height of about 10–20 cm, approximately [21].”
BackgroundNutrition in the prevention and control of osteoporosis
Anta, R. M. O., Ortega, A. I. J., García, R. M. M., Cuadrado‐Soto, E., Aparicio, A., & López-Sobaler, A. M. (2020) · Nutrición Hospitalaria · doi:10.20960/nh.03360 · Cited by 27 · cited 1×
“Nutrients can have a direct or indirect influence on osteoporosis; direct influence is understood as being part of the bone structure itself, while indirect influence is related to the process of absorption and the utilization of calcium [166].”
BackgroundTarantino, U., Cariati, I., Greggi, C., Iundusi, R., Gasbarra, E., Iolascon, G., Kurth, A., Åkesson, K., Bouxsein, M., Leali, P. T., et al. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06482-z · Cited by 27 · cited 4×
“Among the reasons underpinning the low adherence to pharmacotherapy in patients with this pathology is that the asymptomatic nature of the disease maintenance treatment means that the patient sees no manifest benefit from the treatment [112].”
BackgroundInfluentialLi, F., Zhou, C., Xu, L., Tao, S., Zhao, J., & Gu, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149400 · Cited by 26 · cited 1×
“Several preclinical studies have focused on the use of stem cells of different origins [136].”
BackgroundGoshtasebi, A., Berger, C., Barr, S. I., Kovács, C. S., Towheed, T., Davison, K. S., & Prior, J. C. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15051023 · Cited by 25 · cited 1×
“Endocrine factors include: (a) late menarche or menstrual cycle alterations, which are conditions that are associated with low bone mass [26]; (b) surgical or non-surgical menopause before the age of 45 years [27]; (c) being a hormonally infertile woman [28]; and (d) estrogen deficiency before menopause as a result of…”
BackgroundAraghi, S. O., Jong, J. C. K., van Dijk, S. C., Swart, K. M. A., Ploegmakers, K. J., Zillikens, M. C., van Schoor, N. M., de Groot, C. P. G. M., Lips, P. T. A. M., Stricker, B. H. C., et al. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.07.033 · Cited by 24 · cited 1×
“However, the results showed that a chronic intake of folic acid and B-12 has no effect on the risk of fracture [192].”
BackgroundSoy Isoflavones and Breast Cancer
Wu, A. H., Lee, E., & Vigen, C. L. P. (2013) · American Society of Clinical Oncology Educational Book · doi:10.14694/edbook_am.2013.33.102 · Cited by 23
Peris, P., Martinez-Ferrer, A., Monegal, A., de Osaba, M. J. M., Alvarez, L., Ros, I., Muxí, Á., Reyes, R., & Guañabens, N. (2008) · PubMed · Cited by 22
Keen, M., & Reddivari, A. K. R. (2021) · StatPearls · Cited by 22
Osteoporosis Imaging in the Geriatric Patient
Heilmeier, U., Youm, J., Torabi, S., & Link, T. M. (2016) · Current Radiology Reports · doi:10.1007/s40134-016-0144-1 · Cited by 21
Majumdar, S. R., Lier, D. A., McAlister, F. A., Johnson, J. A., Rowe, B. H., & Beaupré, L. A. (2019) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3699 · Cited by 20 · cited 1×
“Moreover, FLS provides an opportunity to improve the adherence to treatment, with a consequent reduction in the risk of refracture [131,132].”
BackgroundYu, P., Liu, Y., Jin, R., Zhang, P., Ding, C., Jiang, X., Xing, J., Bi, B., Xie, J., & Li, J. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00591 · Cited by 20 · cited 1×
“In sCT-OCA, the activity of some osteogenic markers such as ALP increased by up to 63%, and calcium deposition increased by 42%, enhancing osteogenic cell differentiation [157].”
BackgroundChen, Q., Xia, C., Shi, B., Chen, C., Yang, C., Mao, G., & Shi, F. (2021) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-021-00381-w · Cited by 20 · cited 1×
“Their results showed that the combination of ESW and T-Gel significantly enhanced the viability, proliferation, migration and osteogenic differentiation of MSCs, thus improving the osteogenic activity of the microenvironment in osteoporotic defects [164].”
BackgroundIván Quevedo, L., Milka Martínez, B., Marcelo Castillo, N., & Nancy Rivera, F. (2008) · Revista médica de Chile · doi:10.4067/s0034-98872008000400008 · Cited by 18
Calcium Supplements and Fracture Prevention
Huang, J., Ou, H.-Y., & Chiu, K. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1314100 · Cited by 17 · cited 1×
“Although some authors do not support the use of these supplements because of the adverse effects they could have, such as constipation, this is why their use is mainly recommended in postmenopausal women who do not meet the recommended levels through diet [92].”
BackgroundHartman, C., Hochberg, Z., & Shamir, R. (2003) · PubMed · Cited by 17
Current and former smokers and hip fractures
Ampelas, D. G. (2018) · Journal of Frailty Sarcopenia and Falls · doi:10.22540/jfsf-03-148 · Cited by 17 · cited 2×
“Finally, it has been shown that smoking cessation produces an increase in BMD, which reduces the risk of fracture [209]; however, these effects are only appreciable after 10 years of non-consumption [225].”
BackgroundEffect of basal metabolic rate on the bone mineral density in middle to old age women in Taiwan
Hsu, W., Fan, C., Lin, Z., & Hsu, R. W. (2013) · Maturitas · doi:10.1016/j.maturitas.2013.05.016 · Cited by 16 · cited 1×
“Another effect of physical activity related to osteoporosis is related to BMR; cardiovascular and resistance exercise have been shown to increase BMR levels [199].”
BackgroundPredicting osteoporosis with body compositions in postmenopausal women: a non-invasive method
Hsu, W., Hsu, W.-B., Fan, C., & Hsu, R. W. (2021) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-021-02351-3 · Cited by 15 · cited 2×
“[194], in their study, found that a BMR above 1182.”
BackgroundTime to Clinically Relevant Fracture Risk Scores in Postmenopausal Women
Gourlay, M. L., Overman, R. A., Fine, J. P., Crandall, C. J., Robbins, J., Schousboe, J. T., Ensrud, K. E., LeBlanc, E. S., Gass, M. L. S., Johnson, K., et al. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.02.012 · Cited by 14
Nutrition in Cardioskeletal Health
Gallant, K. M. H., Weaver, C. M., Towler, D. A., Thuppal, S. V., & Bailey, R. L. (2016) · Advances in Nutrition · doi:10.3945/an.115.011189 · Cited by 12 · cited 1×
“Nevertheless, at present, controversy has arisen over the consumption of calcium supplements since they are associated with cardiovascular disease [172,173] and, when they are not administered with vitamin D, with the risk of myocardial infarction [174].”
BackgroundFuglsang-Nielsen, R., Rakvaag, E., Vestergaard, P., Hermansen, K., Gregersen, S., & Starup‐Linde, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.832897 · Cited by 11
Osteoporosis involutiva tipo i en la mujer posmenopáusica: diagnóstico y manejo clínico
Jiménez, E. G., Ferré, J. Á., Cano, M. D. P., Jiménez, M., Cordero, M. J. A., & Fernández, J. M. (2009) · Revista Española de Enfermedades Metabólicas Óseas · doi:10.1016/s1132-8460(09)73462-2 · Cited by 9 · cited 2×
“Among all of them, the most frequent kind of osteoporosis is postmenopausal osteoporosis, which is linked to two conditions: menopause and aging [6].”
BackgroundOsteoporotic Hip Fracture in the Elderly Patients: Physicians' Views
Lee, Y., & Koo, K. (2013) · Journal of Korean Medical Science · doi:10.3346/jkms.2013.28.7.976 · Cited by 9 · cited 1×
“These fractures increase exponentially with age and are a major cause of morbidity and mortality in elderly populations [86].”
BackgroundGani, L. U., Tan, F. C. L., & King, T. (2022) · Singapore Medical Journal · doi:10.11622/smedj.2022068 · Cited by 9 · cited 1×
“However, the participation of patients, families, physicians and clinicians is critically important for the success of this tool [123].”
BackgroundNumb chin syndrome associated with metastatic invasive ductal carcinoma of breast
Gopinath, D., Sudha, S., Shameena, P., & Dhanalakshmi, J. (2015) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/0973-029x.164538 · Cited by 6 · cited 1×
“patients without previous radiation therapy or metastatic disease in the jaws [125].”
BackgroundEpidemiology and classification of osteoporosis
Holroyd, C. R., Dennison, E. M., & Cooper, C. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00197-2 · Cited by 6
Ishimi, Y., Taku, K., Umegaki, K., & Yamauchi, J. (2009) · 大豆たん白質研究 · Cited by 3
DeSimone, G. T. (2019) · ACSMʼs Health & Fitness Journal · doi:10.1249/fit.0000000000000524 · Cited by 3
Research works printed but not linked: 2
- Quevedo, 2008, [Vitamin D receptor gene polymorphisms and risk of hip fracture in Chilean elderly women], Rev. Med. Chile, 136, 475
- Società Italiana Dell’osteoporosi del Metabolismo Minerale e delle Malattie dello Scheletro (2004). Clinical Cases in Mineral and Bone Metabolism: The Official Journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, CIC Edizioni Internazionali.
Cited by
Osteoporosis: Molecular Pathology, Diagnostics, and Therapeutics
Adejuyigbe, B., Kallini, J., Chiou, D., & Kallini, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914583 · Cited by 148
“Local molecules such as TGF-β play a pivotal role in attracting and preparing osteoblasts to initiate bone formation [4,6,7].”
InfluentialHsu, S.-H., Chen, L.-R., & Chen, K.-H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212139 · Cited by 117
“Although this condition affects both men and women, it predominantly occurs in women aged 51 to 75, who are characterized by accelerated bone loss during this period [14].”
Cellular senescence in skeletal disease: mechanisms and treatment
He, X., Hu, W., Zhang, Y., Chen, M., Ding, Y., Yang, H., He, F., Gu, Q., & Shi, Q. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00501-5 · Cited by 107
“Unfortunately, although various drugs, (such as bisphosphonates, recombinant human parathyroid hormone, denosumab for OP, and paracetamol for OA), have been licenced, their benefits are limited due to side effects or the poor overall health of elderly individuals (2, 3).”
BackgroundThe emerging role of Piezo1 in the musculoskeletal system and disease
Lei, L., Wen, Z., Cao, M., Zhang, H., Ling, S. K.-K., Fu, S., Qin, L., Xu, J., & Yung, P. S. (2024) · Theranostics · doi:10.7150/thno.96959 · Cited by 83
“In clinical scenarios, appropriate physical activity is beneficial for patients with musculoskeletal disorders, including OP [161], OA [162], muscle atrophy [163], IDD [164], and tendinopathy [165].”
BackgroundFeng, R., Wang, Q. K., Yu, T., Hu, H., Wu, G., Duan, X., Jiang, R., Xu, Y., & Huang, Y. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112341 · Cited by 73
Metadata
- Authors
- Aibar-Almazán, A., Voltes-Martínez, A., Castellote-Caballero, Y., Afanador-Restrepo, D. F., Carcelén-Fraile, M. D. C., & López-Ruiz, E.
- Affiliations
- Department of Health Sciences, Campus de Las Lagunillas SN, University of Jaén, E-23071 Jaén, Spain
- Universidad de Granada (ES)
- Fundación Universitaria del Área Andina (CO)
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-08-21
- Volume
- 23
- Issue
- 16
- Pages
- 9465
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9408932
- OpenAlex
- W4293030541
- Cited by
- 412
- References
- 229
- Citations by year
- 2026: 79 · 2025: 156 · 2024: 128 · 2023: 43 · 2022: 6
- FWCI
- 18.20
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- 2014–2020 Operational Programme FEDER in Andalusia (FMM-AP17196-2019)
- Topics
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Oncology › Bone health and treatments
- Keywords
- osteoporosis, osteoporosis diagnosis, bone densitometry, dual-energy X-ray absorptiometry, anti-resorptive drugs, regenerative medicine, cell therapy, bioactive hydrogels, non-pharmacological treatment, physical activity, diet, smoking, alcohol consumption, bone resorption, bone biology, postmenopausal women, older adults
- MeSH terms
- Aged, Bone Resorption, Female, Humans, Osteoporosis, Smoking, Health Behavior, Exercise, Bone Density, Osteoporosis, Postmenopausal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.